Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Assets Average (2021 - 2025)

Senti Biosciences has reported Assets Average over the past 5 years, most recently at $52.0 million for Q4 2025.

  • For Q4 2025, Assets Average fell 33.2% year-over-year to $52.0 million; the TTM value through Dec 2025 reached $52.0 million, down 33.2%, while the annual FY2025 figure was $74.5 million, 31.41% down from the prior year.
  • Assets Average for Q4 2025 was $52.0 million at Senti Biosciences, down from $60.6 million in the prior quarter.
  • Over five years, Assets Average peaked at $231.8 million in Q3 2021 and troughed at $52.0 million in Q4 2025.
  • A 5-year average of $131.3 million and a median of $125.6 million in 2023 define the central range for Assets Average.
  • Biggest five-year swings in Assets Average: skyrocketed 86.55% in 2022 and later crashed 47.48% in 2024.
  • Year by year, Assets Average stood at $164.2 million in 2021, then grew by 12.75% to $185.1 million in 2022, then crashed by 32.14% to $125.6 million in 2023, then tumbled by 38.08% to $77.8 million in 2024, then plummeted by 33.2% to $52.0 million in 2025.
  • Business Quant data shows Assets Average for SNTI at $52.0 million in Q4 2025, $60.6 million in Q3 2025, and $75.7 million in Q2 2025.